Expression of LIM kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer

BackgroundLIM kinase 1 (LIMK1), a LIM domain containing serine/threonine kinase, modulates actin dynamics through inactivation of the actin depolymerizing protein cofilin. Recent studies have indicated an important role of LIMK1 in growth and invasion of prostate and breast cancer cells; however, the molecular mechanism whereby LIMK1 induces tumor progression is unknown. In this study, we investigated the effects of ectopic expression of LIMK1 on cellular morphology, cell cycle progression and expression profile of LIMK1 in prostate tumors.ResultsEctopic expression of LIMK1 in benign prostatic hyperplasia cells (BPH), which naturally express low levels of LIMK1, resulted in appearance of abnormal mitotic spindles, multiple centrosomes and smaller chromosomal masses. Furthermore, a transient G1/S phase arrest and delayed G2/M progression was observed in BPH cells expressing LIMK1. When treated with chemotherapeutic agent Taxol, no metaphase arrest was noted in these cells. We have also noted increased nuclear staining of LIMK1 in tumors with higher Gleason Scores and incidence of metastasis.ConclusionOur results show that increased expression of LIMK1 results in chromosomal abnormalities, aberrant cell cycle progression and alteration of normal cellular response to microtubule stabilizing agent Taxol; and that LIMK1 expression may be associated with cancerous phenotype of the prostate.

[1]  M. Hirai,et al.  Identification and Characterization of a Novel Family of Serine/Threonine Kinases Containing Two N-terminal LIM Motifs (*) , 1995, The Journal of Biological Chemistry.

[2]  H. Tanke,et al.  Identification of Genetic Markers for Prostatic Cancer Progression , 2000, Laboratory Investigation.

[3]  LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505. , 2001, The Biochemical journal.

[4]  L. Chung,et al.  New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions. , 2003, Urology.

[5]  E. Nishida,et al.  Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization , 1998, Nature.

[6]  T. H. Wang,et al.  Paclitaxel‐induced cell death , 2000, Cancer.

[7]  J. Baldassare,et al.  Ras-stimulated Extracellular Signal-related Kinase 1 and RhoA Activities Coordinate Platelet-derived Growth Factor-induced G1 Progression through the Independent Regulation of Cyclin D1 and p27KIP1 * , 1997, The Journal of Biological Chemistry.

[8]  R. Dahiya,et al.  Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1 , 2007, In Vitro Cellular & Developmental Biology - Animal.

[9]  D. C. Edwards,et al.  Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics , 1999, Nature Cell Biology.

[10]  G. Bokoch,et al.  Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells , 1997, Current Biology.

[11]  U. Manne,et al.  Factors Affecting Immunohistochemical Evaluation of Biomarker Expression in Neoplasia , 1998 .

[12]  Toshikazu Nakamura,et al.  Mitosis-dependent phosphorylation and activation of LIM-kinase 1. , 2002, Biochemical and biophysical research communications.

[13]  A. Sahin,et al.  LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase‐type plasminogen activator system , 2006, International journal of cancer.

[14]  G. Pihan,et al.  Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. , 2003, Cancer research.

[15]  J. Marx.  Cell biology. Do centrosome abnormalities lead to cancer? , 2001, Science.

[16]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[17]  J. Marx.  Do Centrosome Abnormalities Lead to Cancer? , 2001, Science.

[18]  O. Bernard,et al.  A role for LIM kinase in cancer invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Doxsey.  Duplicating dangerously: linking centrosome duplication and aneuploidy. , 2002, Molecular cell.

[20]  O. Bernard,et al.  LIM Kinase 2 Is Widely Expressed in All Tissues , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  Michael F. Olson,et al.  The Rho GTPase Effector ROCK Regulates Cyclin A, Cyclin D1, and p27Kip1 Levels by Distinct Mechanisms , 2006, Molecular and Cellular Biology.

[22]  S. Narumiya,et al.  Rho-associated Kinase ROCK Activates LIM-kinase 1 by Phosphorylation at Threonine 508 within the Activation Loop* , 2000, The Journal of Biological Chemistry.

[23]  M. Pepe.  The Statistical Evaluation of Medical Tests for Classification and Prediction , 2003 .

[24]  L. Chung,et al.  Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. , 2002, Differentiation; research in biological diversity.

[25]  D. Bostwick,et al.  Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. , 1999, The Journal of urology.

[26]  K. Mizuno,et al.  Cytoplasmic localization of LIM-kinase 1 is directed by a short sequence within the PDZ domain. , 1998, Experimental cell research.

[27]  J. Niu,et al.  LIM Kinase 1 Coordinates Microtubule Stability and Actin Polymerization in Human Endothelial Cells* , 2005, Journal of Biological Chemistry.

[28]  R. Chakrabarti,et al.  LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. , 2003, The Journal of biological chemistry.

[29]  James M. Roberts,et al.  Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors? , 2004, Nature Reviews Cancer.

[30]  O. Bernard.  Lim kinases, regulators of actin dynamics. , 2007, The international journal of biochemistry & cell biology.

[31]  T. Obinata,et al.  Functional involvement of Xenopus LIM kinases in progression of oocyte maturation. , 2001, Developmental biology.

[32]  S. Sebti,et al.  p21WAF1/CIP1 Is Upregulated by the Geranylgeranyltransferase I Inhibitor GGTI-298 through a Transforming Growth Factor β- and Sp1-Responsive Element: Involvement of the Small GTPase RhoA , 1998, Molecular and Cellular Biology.

[33]  K. Mizuno,et al.  Nuclear export of LIM-kinase 1, mediated by two leucine-rich nuclear-export signals within the PDZ domain. , 1999, The Biochemical journal.

[34]  J. K. Day,et al.  Centrosome‐centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model , 2000, Biology of the cell.

[35]  L. Liotta,et al.  Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. , 2001, Cancer research.

[36]  T. Akiyama,et al.  Suppression of fibroblast cell growth by overexpression of LIM‐kinase 1 , 1996, FEBS letters.

[37]  K. Kuma,et al.  Identification of a human cDNA encoding a novel protein kinase with two repeats of the LIM/double zinc finger motif. , 1994, Oncogene.

[38]  U. Manne,et al.  Immunohistochemical Evaluation of Biomarkers in Prostatic and Colorectal Neoplasia , 1998 .

[39]  K. Ohashi,et al.  Mitosis-specific Activation of LIM Motif-containing Protein Kinase and Roles of Cofilin Phosphorylation and Dephosphorylation in Mitosis* , 2002, The Journal of Biological Chemistry.

[40]  Keiji Tanaka,et al.  p57Kip2 Regulates Actin Dynamics by Binding and Translocating LIM-kinase 1 to the Nucleus* , 2003, Journal of Biological Chemistry.

[41]  J. Bamburg,et al.  Xenopus laevis actin-depolymerizing factor/cofilin: a phosphorylation- regulated protein essential for development , 1996, The Journal of cell biology.

[42]  Carol Reynolds,et al.  Centrosome amplification drives chromosomal instability in breast tumor development , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Moseley,et al.  Soluble and Transmembrane Isoforms of Novel Interleukin-17 Receptor-like Protein by RNA Splicing and Expression in Prostate Cancer* , 2002, The Journal of Biological Chemistry.